問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
楊勝雄
下載
2019-05-01 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2024-09-01 - 2038-12-31
Participate Sites9Sites
Recruiting9Sites
2021-03-01 - 2028-08-31
Participate Sites5Sites
Recruiting5Sites
2023-03-27 - 2029-07-30
Not yet recruiting5Sites
Recruiting1Sites
2020-09-15 - 2025-10-08
Participate Sites7Sites
Terminated1Sites
2021-02-01 - 2026-02-01
Participate Sites1Sites
2020-04-01 - 2025-11-26
Not yet recruiting2Sites
Recruiting4Sites
2018-09-01 - 2022-03-31
Severe eosinophilic leukocyte asthma
Benralizumab
Participate Sites8Sites
Recruiting8Sites
Division of Thoracic Medicine
2018-05-01 - 2023-09-30
TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer
Keytruda injection
Participate Sites15Sites
Terminated13Sites
全部
